Author:
Nordeng Hedvig,Jirsová Eva,Spigset Olav
Publisher
Springer International Publishing
Reference34 articles.
1. Nordeng H, van Gelder M. Chapter 3.3.1. Drug utilization studies in pregnant women. In: Drug utilization research—methods and applications. Wiley; 2024.
2. Ceulemans M, Lupattelli A, Nordeng H, Odalovic M, Twigg M, Foulon V. Women’s beliefs about medicines and adherence to pharmacotherapy in pregnancy: opportunities for community pharmacists. Curr Pharm Des. 2019;25(5):469–82. https://doi.org/10.2174/1381612825666190321110420.
3. Petersen I, McCrea RL, Lupattelli A, Nordeng H. Women’s perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey. BMJ Open. 2015;5(6):e007390. https://doi.org/10.1136/bmjopen-2014-007390.
4. Mahmood T, Savona-Ventura C, Messinis I, Mukhopadhyay S. The EBCOG postgraduate textbook of obstetrics and gynaecology. Cambridge: Cambridge University Press; 2021.
5. Schaefer C, Peters PWJ, Miller RK. Drugs during pregnancy and lactation: treatment options and risk assessment. 3nd ed. Amsterdam: Elsevier Academic Press; 2014.